Phannacokinetics and lung tissue concentration of valnemulin in swine

Journal of Animal and Veterinary Advances

Volumn 10, Issue 14, 2011, Pages 1824-1828

  Zhang, Z ^a   Zhang, C Y ^a   Guo, J P ^a   Zhu, L X ^a   Luo, X V ^a   Wang, R ^a   Liu, Y H ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866645896     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2011.1824.1828     Document Type: Article

References (19)

1. Birch, AI., CW. Holzapfel andRW. Rickards, 1996. The structure and some aspects of the biosynthesis of pleuromutilin. Tetrahedron, 22: 359-387.
2. Bowman, W.C and M.J. Rand, 1980. Textbook of Pharmacology. 2nd Edn., Blackwell Scientific Publications, Oxford, pp: 39-25.
3. Buur, J.L, 2007. Applications of physiologically based phannacokinetic models in veterinary medicine. Ph.D. Thesis, North Carolina State University.
4. Gabrielsson, J. andD. Weiner, 1997. Non-Compartmental Analysis in Pharmacokinetic/Pharmacodynamic Data Analysis: Concepts and Applications. 2nd EOO., Johan Gabrielsson and Daniel Weiner, Swedish Pharmaceutical Press, Stockhohn, pp: 138-152.
5. Gentry, DR, L. McCloskey, M.N. Gwynn, S.F. Rittenhouse, N. Scangarella, R Shawar and nJ. Holmes, 2008. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus antimicrobial agents and chemotherapy. Antimicrob. Agents Chemother., 52: 4507-4509.
6. Harman, P.CT. and P.R. Ripley, 1996. In vitro development of resistance III Mycoplasma hyopneurnoinae to SDZ PMD 296, tiamulin and two other antimicrobial agents. Proc. Int. Congr. Pig. Vet. Soc., 14: 225-225.
7. Hauschke, N, V. Steinijans and I. Pigeot, 2007. Basic Statistical Considerations. In: Bioequivalence Studies in Drug Development Methods and Applications, Hauschke, D., V. Steiinjans and I. Pigeot (Eds.). John Wiley and Sons Ltd., San Francisco, USA, pp: 37-68.
8. Hidalgo, A., A. Carvajala, G Garcia-Feliza, J. Osorioa and P. Rubio, 2009. Antimicrobial susceptibility testing of Spanish field isolates of Brachyspira hyodysenteriae. Res. Vet. Sci., 87: 7-12.
9. Horkovics-Kovats, S. and F. Schatz, 1996. Physiologically based pharmacokinetic modelling with valnemulin and its metabolites after multiple oral administration in pigs. I. Pharm. Med., 6: 149-167.
10. Horkovics-Kovats, S. and F. Schatz, 1997. Pharmacokinetic modelling with valnemulin and its total metabolites after multiple oral administration to pigs. I. Vet. Pharmacol. Therapeutics, 20: 29-29.
11. Hu, GH. and Y. Zou, 2009. Mutilins derivatives: From veterinary to Human-used antibiotics. Mini Rev. Med. Chem., 9: 1397-1406.
12. Huang, Q., I. Li, L. Xia, X Xia, P. Duan, I. Shen and S. Ding, 201 o. Residue depletion of valnemulin in swine tissues after oral administration. Anal. Chim. Acta, 664: 62-67.
13. Lobova, D., J. Smola and A. Cizek, 2004. Decreased susceptibility to tiamulin and valnemulin among Czech isolates of Brachyspira hyodysenteriae. J. Med. Microbiol., 53: 287-291.
14. Martinez, M.N., 1998. Noncompartrnental methods of drug characterization: Statistical moment theory. J. Am. Vet. Med. Association, 213: 974-980.
15. Riviere, I.E., 1999. Study Design and Data Analysis. In: Comparative Pharmacokinetics: Principles, Techniques and Applications, Riviere, J.E. et al. (Eds.). 1st Edn., Iowa State Uinversity Press, USA.
16. Ross, RF., 1999. Mycoplasmal Pneumonia of Swine. In: Disease of Swine, Straw, B.E., S. D'Allaire, W.L. Mengeling and nI. Taylor (Eds.). 8th Edn., Iowa State University Press, Ames, Iowa, USA.
17. Toutain, P.L. and A Bousquet-Melou, 2004. Bioavailability and its assessment. J. Vet. Pharmacol. Therapeutics, 27: 455-466.
18. Wang, R, L.G. Yuan, L.M. He, LX Zhu and x.v. Luo et al, 2010. Pharmacokinetics and bioavailability of valnemulin in broiler chickens. J. Vet. Pharmacol. Therapeut., 34: 247-251.
19. Yamaoka, K, T. Nakagawa and T. Uno, 1978. Application of Akaike's Information Criterion (AlC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinetics Biopharmaceut., 6: 165-175.